Community pharmacists’ views about prescription medicine co-payments and potential implications for equitable access to medicines: a critical realist interpretation

References

• National Institute for Health and Care Excellence. Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes 2015 [cited Nov 12 2021]. Available from: https://www.nice.org.uk/guidance/ng5.
   Google Scholar
• World Health Organization. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies: World Health Organization, Geneva. 2010.
   Google Scholar
• World Health Organization. The legal and regulatory framework for community pharmacies in the WHO European Region. 2019. Report No.: 9289054247.
   Google Scholar
• Barnieh L, Clement F, Harris A, Blom M, Donaldson C, Klarenbach S, et al.A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and developmentPLoS ONE201493e90434 10.1371/journal.pone.0090434 24618721 3949707
   PubMed Web of Science ®Google Scholar
• Luiza VL, Chaves LA, Silva RM, Emmerick ICM, Chaves GC, Fonseca de Araújo SC, et al.Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesCochrane Database Syst Rev201520155CD007017 25966337 7386822
   PubMedGoogle Scholar
• Epp J, Parkinson B, Hawse S. Health system sustainability: the pharmaceutical benefits scheme in Australia. Industry and Higher Education: Springer; 2020. p. 13–44.
   Google Scholar
• Gupta S, McColl MA, Guilcher SJ, Smith KCost-related nonadherence to prescription medications in Canada: a scoping reviewPatient Prefer Adherence20181216991715 10.2147/PPA.S170417 30233150 6134942
   PubMed Web of Science ®Google Scholar
• Ong SE, Kai Koh JJ, Toh SAES, Chia KS, Balabanova D, McKee M, et al. Assessing the influence of health systems on type 2 diabetes mellitus awareness, treatment, adherence, and control: a systematic review. PLoS ONE. 2018;13(3).
   Google Scholar
• Jatrana S, Crampton P, Norris PEthnic differences in access to prescription medication because of cost in New ZealandJ Epidemiol Community Health2011655454460 10.1136/jech.2009.099101 20466707
   PubMed Web of Science ®Google Scholar
• Jatrana S, Richardson K, Norris P, Crampton PIs cost-related non-collection of prescriptions associated with a reduction in health? Findings from a large-scale longitudinal study of New Zealand adultsBMJ Open2015511 10.1136/bmjopen-2015-007781 26553826 4654342
   PubMed Web of Science ®Google Scholar
• Bentur N, Gross R, Brammli-Greenberg SSatisfaction with and access to community care of the chronically ill in Israel’s health systemHealth Policy2004672129136 10.1016/S0168-8510(03)00086-1 14720631
   PubMed Web of Science ®Google Scholar
• Jeon YH, Essue B, Jan S, Wells R, Whitworth JA. Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Serv Res. 2009;9.
   Google Scholar
• Goodyear-Smith F, Ashton TNew Zealand health system: universalism struggles with persisting inequitiesThe Lancet201939410196432442 10.1016/S0140-6736(19)31238-3
   PubMed Web of Science ®Google Scholar
• Thomson S, Cylus J, Evetovits T. Can people afford to pay for health care? New evidence on financial protection in Europe: World Health Organization. Regional Office for Europe; 2019.
   Google Scholar
• World Health Organization. Health Equity: Social determinants of health: WHOS; 2022 [cited 6 May 2022]. Available from: https://www.who.int/health-topics/social-determinants-of-health#tab=tab_3.
   Google Scholar
• Health and Disability System Review. Health and Disability System Review‐Interim report. Wellington: HDSR 2019.
   Google Scholar
• New Zealand Ministry of Health. Prescription Subsidy Scheme: New Zealand Ministry of Health; 2023 [updated 01 June 2023; cited 24 Nov 2023]. Available from: https://www.health.govt.nz/your-health/conditions-and-treatments/treatments-and-surgery/medications/prescription-subsidy-scheme.
   Google Scholar
• Norris P, Cousins K, Horsburgh S, Keown S, Churchward M, Samaranayaka A, et al.Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trialBMC Health Serv Res2023231111
   PubMed Web of Science ®Google Scholar
• Manch T. Budget 2023: National vows to bring back $5 prescription fees if elected: Stuff; 2023 [18 May 2023]. Available from: https://www.stuff.co.nz/national/politics/132083751/budget-2023-national-vows-to-bring-back-5-prescription-fees-if-elected.
   Google Scholar
• Patwardhan A, Davis J, Murphy P, Khandelwal N, Sherman B, Manfred JThe impact of 90-day prescriptions on adherence at workplace pharmacies compared to traditional mail orderPopul Health Manag2011146285291 10.1089/pop.2010.0076 22092153
   PubMed Web of Science ®Google Scholar
• Stoneman J, Taylor SJPharmacists’ views on Indigenous health: is there more that can be done?Rural Remote Health200773743 1:STN:280:DC%2BD2svntVCgsg%3D%3D 17688377
   PubMedGoogle Scholar
• Napier P. The introduction of an advanced role for pharmacy technicians into the New Zealand pharmacy setting (Thesis, Doctor of Philosophy) University of Otago: University of Otago; 2017. Available from: http://hdl.handle.net/10523/7702.
   Google Scholar
• Norris P, Tordoff J, McIntosh B, Laxman K, Chang SY, Te Karu LImpact of prescription charges on people living in poverty: a qualitative studyRes Social Adm Pharm2016126893902 10.1016/j.sapharm.2015.11.001 26681431
   PubMed Web of Science ®Google Scholar
• Kjoenniksen I, Lindbaek M, Granas AGPatients’ attitudes towards and experiences of generic drug substitution in NorwayPharm World Sci2006285284289 10.1007/s11096-006-9043-5 17111247
   PubMedGoogle Scholar
• Gossell-Williams MGeneric substitutions: a 2005 survey of the acceptance and perceptions of physicians in JamaicaWest Indian Med J2007565458 1:STN:280:DC%2BD1c7ksFCguw%3D%3D 18303760
   PubMed Web of Science ®Google Scholar
• Jones Z. The effect of the increase in prescription charges on Community Pharmacy in New Zealand. [Unpublished report]. 2014.
   Google Scholar
• Chaar B, Brien J, Krass IProfessional ethics in pharmacy: the Australian experienceInt J Pharm Pract2005133195204 10.1211/ijpp.13.3.0005
   Google Scholar
• McDonald S, Lopatka H, Bachynsky J, Kirwin D. Systematic review of pharmacy reimbursement literature. University of Alberta; 1999.
   Google Scholar
• Huttin CA critical review of the remuneration systems for pharmacistsHealth Policy19963615368 1:STN:280:DyaK283gslKisQ%3D%3D 10.1016/0168-8510(95)00796-2 10157820
   PubMed Web of Science ®Google Scholar
• Napier P, Norris P, Green J, Braund RExperiences of pharmacy staff during the introduction of the checking technician role in New ZealandInt J Pharm Pract2019272149 10.1111/ijpp.12483 30252175
   PubMed Web of Science ®Google Scholar
• Khan SMedicare Part D: pharmacists and formularies—whose job is it to address copaysConsult Pharm2014299602613 10.4140/TCP.n.2014.602.25203409
   PubMedGoogle Scholar
• Norris P, Wilson SE, Green JA, Gu J, Goddard S, Deadman LR, et al.Knowledge and attitudes to prescription charges in New Zealand and EnglandRes Social Adm Pharm2018142180186 10.1016/j.sapharm.2017.02.016 28279613
   PubMed Web of Science ®Google Scholar
• Metcalfe S, Beyene K, Urlich J, Jones R, Proffitt C, Harrison J, et al.Te Wero tonu—the challenge continues: Māori access to medicines 2006/07–2012/13 updateN Z Med J201813114852747 30408816
   PubMed Web of Science ®Google Scholar
• Yin RKCase study research and applications20186Los AngelesSAGE Publications
   Google Scholar
• Aspers P, Corte UWhat is qualitative in qualitative researchQual Sociol2019422139160 10.1007/s11133-019-9413-7 31105362 6494783
   PubMed Web of Science ®Google Scholar
• DeCarlo M. Scientific inquiry in social work 2018 [cited 2021. Available from: https://scientificinquiryinsocialwork.pressbooks.com/chapter/8-4-qualitative-research-questions/.
   Google Scholar
• Jagosh JRealist synthesis for public health: building an ontologically deep understanding of how programs work, for whom, and in which contextsAnnu Rev Public Health201940361372 10.1146/annurev-publhealth-031816-044451 30633712
   PubMed Web of Science ®Google Scholar
• Jagosh JRetroductive theorizing in Pawson and Tilley’s applied scientific realismJ Crit Realism2020192121130 10.1080/14767430.2020.1723301
   Web of Science ®Google Scholar
• Braun V, Clarke VThematic analysis: a practical guide2021LondonSage
   Google Scholar
• Alderson PCritical realism for health and illness research: a practical introduction2021BristolBristol University Press 10.2307/j.ctv1fcf8g0
   Google Scholar
• Smith AJ, Scahill SL, Harrison J, Carroll T, Medlicott NJService provision in the wake of a new funding model for community pharmacyBMC Health Serv Res2018181307 10.1186/s12913-018-3120-z 29716610 5930839
   PubMedGoogle Scholar
• Foster R, Preval N, Blakely T, Wilson N, Desmond James OD. Costing of pharmaceuticals in New Zealand for health economic studies: backgrounder and protocol for costing Technical Report: Number 6. Department of Public Health, University of Otago, Wellington; 2011. Report No.: no.0473198525.
   Google Scholar
• Bay of Plenty District Health Board. Bay of Plenty District Health Board, Hauora A Toi, Annual Report 2021. BOP DHB; 2021.
   Google Scholar
• Qualtrics [Internet]. www.qualtrics.com. 2005 [cited 2023]. Available from: https://www.qualtrics.com/blog/citing-qualtrics/.
   Google Scholar
• Otter [Internet]. 2022. Available from: www.otter.ai.
   Google Scholar
• Wiltshire G, Ronkainen NA realist approach to thematic analysis: making sense of qualitative data through experiential, inferential and dispositional themesJ Crit Realism2021202159180 10.1080/14767430.2021.1894909
   Web of Science ®Google Scholar
• Fryer T. A critical realist approach to thematic analysis: producing causal explanations. J Crit Realism. 2022:1–20.
   Google Scholar
• Peacocke E.F “It’s my role to ensure that they have access to medicines”: insights from community pharmacists about prescription medicine co-payments and possible implications for equitable access [MPH Dissertation]. Unpublished: University of Otago, New Zealand; 2022.
   Google Scholar
• New Zealand Treasury. Budget 2012 Information Release: T2011/2570: Improving the Targeting of Co-payments in Primary Care: New Zealand Treasury; 2012 [cited 2022 June 27].
   Google Scholar
• Drummond M, Towse AIs it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?Eur J Health Econ201213115 10.1007/s10198-011-0353-8 22042321
   PubMed Web of Science ®Google Scholar
• Waitangi Tribunal. Hauora: Report on stage one of the health services and outcomes kaupapa inquiry: Waitangi Tribunal; 2019 [cited 2022 April 10]. Available from: https://waitangitribunal.govt.nz/news/report-on-stage-one-of-health-services-and-outcomes-released/.
   Google Scholar
• Came H, Tudor KUnravelling the whāriki of Crown Māori health infrastructureN Z Med J201713014584247 28694538
   PubMedGoogle Scholar
• New Zealand Cabinet Māori Crown Relations: Te Arawhiti Committee. Treaty of Waitangi guidance (MCR-19-MIN-0024). In: Wellington Cabinet Office, editor. Wellington: Cabinet Office; 2019.
   Google Scholar
• Graham R, Masters-Awatere BExperiences of Māori of Aotearoa New Zealand’s public health system: a systematic review of two decades of published qualitative researchAust N Z J Public Health2020443193200 10.1111/1753-6405.12971 32311187
   PubMed Web of Science ®Google Scholar
• Health and Disability System Review. Health and Disability System Review—Final Report—Pūrongo Whakamutunga. Wellington: HDSR; 2020.
   Google Scholar
• Tinirau R, Smith C, Haami M. Whakatika: International Literature Review. Whanganui: Te Atawhai o Te Ao Charitable Trust; 2021.
   Google Scholar
• Durie MWhaiora: Maōri health development1998Oxford University Press
   Google Scholar
• World Health Organization. Social Determinants of Health 2021 [cited 1 September 2022]. Available from: https://www.who.int/health-topics/social-determinants-of-health.
   Google Scholar
• Hikaka J, Jones R, Hughes C, Connolly M, Martini NEthnic variations in the quality use of medicines in older adults: Māori and Non-Māori in Aotearoa New ZealandDrugs Aging2021383205217 10.1007/s40266-020-00828-0 33432516
   PubMed Web of Science ®Google Scholar
• Lee S, Collins FL, Simon-Kumar RBlurred in translation: the influence of subjectivities and positionalities on the translation of health equity and inclusion policy initiatives in Aotearoa New ZealandSoc Sci Med2021288 10.1016/j.socscimed.2020.113248 32753115
   PubMed Web of Science ®Google Scholar
• Reid P, Cormack D, Paine S-JColonial histories, racism and health—the experience of Māori and Indigenous peoplesPublic Health2019172119124 1:STN:280:DC%2BB3M3jvF2ntQ%3D%3D 10.1016/j.puhe.2019.03.027 31171363
   PubMed Web of Science ®Google Scholar
• PHARMAC. Achieving medicine access equity in Aotearoa New Zealand: towards a theory of change: PHARMAC; 2019 [Available from: https://pharmac.govt.nz/about/what-we-do/equity/achieving-medicine-access-equity-in-aotearoa-new-zealand-towards-a-theory-of-change/.
   Google Scholar
• Health Quality & Safety Commission New Zealand. Atlas of healthcare variation Wellington: HQSC; 2021 [cited 12 April 2023]. Available from: https://www.hqsc.govt.nz/our-programmes/health-quality-evaluation/projects/atlas-of-healthcare-variation/.
   Google Scholar
• New Zealand Ministry of Health. Key indicators: Results from the 2019/20 New Zealand Health Survey Wellington New Zealand: Ministry of Health; 2021 [updated April 1; cited 14 September 2022]. December 2021: [Available from: https://www.health.govt.nz/publication/annual-update-key-results-2020-21-new-zealand-health-survey.
   Google Scholar
• Weller T, Jamieson CThe expanding role of the antibiotic pharmacistJ Antimicrob Chemother2004542295298 1:CAS:528:DC%2BD2cXnt1Wis78%3D 10.1093/jac/dkh327 15201228
   PubMed Web of Science ®Google Scholar